Margins Stumble but Orders Surge, Warrants Cleared: A Tale of Two Quarters

What happened

FreightCar America reported a sharply lower gross margin of 5.5% in Q2 2026, down from 15.0% a year ago, as $2.2 million in workforce realignment costs and apparent pricing or mix headwinds pushed adjusted EBITDA to just $1.2 million, far below the $9.3 million achieved in the prior-year quarter. In stark contrast, the company's order intake soared, driving backlog up 121% sequentially to $344 million on 3,972 units, signaling exceptional demand. The quarter also saw the resolution of a major overhang: outstanding warrants were exercised, slashing the warrant liability from $119.4 million to $14.0 million and restoring positive stockholders' equity of $36.2 million. Operating cash flow came in at $12.1 million, with free cash flow up 43% year-over-year, though this was supported by working capital shifts. CEO Nick Randall noted the period reflected two different realities—weak current profitability but a dramatically improved order book and balance sheet.

Implication

Investors should recognize that while FreightCar America's Q2 2026 earnings nearly vanished, the massive backlog build and warrant resolution have transformed the company's risk profile. The $344 million backlog, well above our bull case of $300 million, provides several quarters of revenue visibility, and the elimination of the warrant overhang strengthens equity and reduces dilution risk. However, the margin collapse—even adjusted for restructuring—raises doubts about pricing power and cost control that must be resolved before the backlog can be converted into value. Cash flow remains positive but thin, leaving little room for error. The next few quarters will be critical: if margins can recover toward double digits as the new orders flow through, the stock could re-rate significantly; if not, the strong backlog will simply defer a reckoning.

Thesis delta

Our base case of ~$40M+ EBITDA for FY25 and mid-$30M for FY26 is now clearly at risk after a 1% adjusted EBITDA margin quarter, suggesting the earnings trough is deeper than expected. However, the backlog has jumped to a level that exceeds our bull-case scenario, and the warrant exercise removes a key source of dilution and negative equity. This shifts the investment thesis from waiting for stabilization to betting on a margin recovery; we would seek evidence of improving gross margins before raising conviction, but the improved balance sheet and order book support a higher floor under the stock.